-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol3/Advances-McCabe_39.pdf
March 28, 2008 - Using Data Mining to Predict Errors in Chronic Disease Care
Using Data Mining to Predict Errors
in … Chronic Disease Care
Ryan M. … use in identifying decision
strategies that lead to encounter-specific treatment errors in chronic disease … patients are not at evidence-based goals), a particular
area of interest in the treatment of chronic diseases … Application of this work to the improvement of care for patients with type 2 diabetes, as
well as chronic diseases
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/jhFZhsK8x-mHaN9wU9zhaF
Screening for Chronic Obstructive Pulmonary Disease: Clinical Summary
Figure. … Screening for Chronic Obstructive Pulmonary Disease: Clinical Summary
Population Asymptomatic adults … present with respiratory symptoms
Recommendation
Do not screen for chronic obstructive pulmonary disease
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cAs__BR8J4rgcZ4vQgfaTx
April 01, 2009 - Screening for Coronary Heart Disease: Clinician Fact Sheet
How is risk for CHD
traditionally determined … This fact sheet for clinicians provides
information about screening for coronary heart disease (CHD) … Should patients be routinely screened for
coronary heart disease (CHD) beyond
conventional CHD risk … Screening for Coronary Heart Disease:
Recommendation Statement. February 2004. … A screening test is routinely recommended only if:
y Early treatment of the disease is more effective
-
effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease
-
effectivehealthcare.ahrq.gov/products/crohns-disease-future/research
-
effectivehealthcare.ahrq.gov/products/cervical-degenerative-disease/research
-
effectivehealthcare.ahrq.gov/products/risk-cardiovascular-disease/protocol
-
effectivehealthcare.ahrq.gov/products/renal-disease-iron/abstract
-
effectivehealthcare.ahrq.gov/products/renal-disease-anemia/abstract
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017035-mehr-final-report-2011.pdf
January 01, 2011 - Using HIT to Improve Ambulatory Chronic Disease Care
Grant Final Report____________________________ … _______________
Grant ID: HS017035
Using HIT to Improve Ambulatory Chronic Disease Care
Inclusive … implementing an electronic medical record absent specific
strategies to manage patients with chronic diseases … any of the primary care clinics between April 2006 and April 2008 who had any of several
chronic diseases … Care for chronic diseases: the efficacy of coordinated and patient
centred care is established, but
-
meps.ahrq.gov/data_files/publications/st531/stat531.pdf
July 01, 2020 - Healthcare Expenditures for Heart Disease among Adults Age 18 and Older in the U.S. … disease, angina,
heart attacks, dysrhythmias, and heart failure. … CIR001 Chronic rheumatic heart disease
CIR002 Acute rheumatic heart disease
CIR003 Nonrheumatic and … Expenditures for Heart Disease among Adults Age 18 and Older:
Estimates for the U.S. … Healthcare Expenditures for Heart Disease among Adults Age
18 and Older in the U.S.
-
digital.ahrq.gov/ahrq-funded-projects/success-stories/text-messaging-managing-chronic-disease
January 01, 2023 - Text Messaging for Managing Chronic Disease
Your browser does not support
-
psnet.ahrq.gov/primer/coronavirus-disease-2019-covid-19-and-diagnostic-error
July 30, 2020 - Coronavirus Disease 2019 (COVID-19) and Diagnostic Error. PSNet [internet]. … The Infectious Diseases Society of America continues to recommend NAATs as the diagnostic method of choice … negative rate would be 23% when the pre-test probability of COVID-19 is 50%. 54 Hence, the Infectious Diseases … Infectious Diseases Society of America; Version 1.0.0. Accessed August 30, 2021. … Infectious Diseases Society of America; Version 2.0.0. Accessed August 30, 2021.
-
meps.ahrq.gov/data_files/publications/st531/stat531.shtml
July 01, 2020 - STATISTICAL BRIEF #531:
Healthcare Expenditures for Heart Disease among Adults Age 18 and Older … The percentage of adults with reported expenses for heart disease was higher for those age 65 and older … treatment in adults.² Heart disease as defined for this Statistical Brief includes coronary artery disease … CIR001
Chronic rheumatic heart disease
CIR002
Acute rheumatic heart disease … Expenditures for Heart Disease among Adults Age 18 and Older: Estimates for the U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
November 15, 2012 - , lysosomal storage diseases, and rare diseases. … Enzyme reconstitution/replacement
therapy for lysosomal storage diseases. … Current strategies in the management of lysosomal storage diseases. … Update on treatment of lysosomal storage
diseases. Acta Myol 2007 Jul;26(1):87-92. … Diseases with FDA-approved Enzyme Replacement Therapy*
Disease
[estimated
incidence]
Symptoms
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-1416-p007-1-ef.pdf
November 01, 2015 - Timeliness of Confirmatory Testing for Sickle Cell Disease: Timeliness of Antibiotic Prophylaxis for … Management of children with sickle cell disease: a comprehensive review of the
literature. … The management of sickle cell disease. In: National Institutes of Health, ed. … Population estimates of sickle cell disease in the U.S. … Newborn screening for sickle cell disease: effect on mortality.
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
April 25, 2024 - in progress
Draft Research Plan
Enhanced Risk Assessment for Cardiovascular Disease … What is the effectiveness or comparative effectiveness of enhanced cardiovascular disease risk assessment … What are other risk markers used in enhanced cardiovascular disease risk assessment and what is their … What are the limitations of existing cardiovascular disease risk assessment or use of coronary artery … coronary heart disease, cerebrovascular disease, and peripheral artery disease
Heart failure
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/aspirin-narrative.pdf
December 31, 2018 - Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic Measure Narrative
Ischemic … Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
Measure Narrative
Description … the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular
disease … Ages
18 years and older as of the first date of the measurement period
Ischemic Vascular Disease … (Ischemic Vascular Disease Value Set) at any
time during the current measurement period;
• discharged
-
psnet.ahrq.gov/web-mm/inflicting-confusion
August 04, 2021 - A primary subtype of inflammatory bowel disease (IBD), Crohn disease can cause inflammation in any segment … The ileum is the most common site of inflammation in Crohn disease, and colonic disease is the second … Impact of Clostridium difficile on inflammatory bowel disease. … Anti-tuberculous therapy for maintaining remission of Crohn's disease. … Infliximab, azathioprine, or combination therapy for Crohn's disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/celiac-disease_clinician.pdf
July 01, 2016 - Diagnosis of Celiac Disease: Current State of the Evidence
Diagnosis of Celiac Disease: Current State … It is useful
for ruling out but not diagnosing celiac disease. … , and several autoimmune
diseases (including type 1 diabetes). … of celiac disease. … http://www.effectivehealthcare.ahrq.gov/celiac-disease
http://www.effectivehealthcare.ahrq.gov/celiac-disease